|
Originally published In Press as doi:10.1074/jbc.M303716200 on May 5, 2003
J. Biol. Chem., Vol. 278, Issue 29, 27105-27111, July 18, 2003
Enhanced Immune Presentation of a Single-chain Major Histocompatibility Complex Class I Molecule Engineered to Optimize Linkage of a C-terminally Extended Peptide*
Lonnie Lybarger ,
Y. Y. Lawrence Yu ,
Michael J. Miley ¶,
Daved H. Fremont ¶,
Nancy Myers ,
Tina Primeau ,
Steven M. Truscott ,
Janet M. Connolly and
Ted H. Hansen ||
From the
Departments of Genetics and
¶Pathology and Immunology, Washington University
School of Medicine, St. Louis, Missouri 63110
Major histocompatibility complex class I molecules can be expressed as
single polypeptides wherein the antigenic peptide,
2-microglobulin, and heavy chain are attached by flexible
linkers. These molecules, single-chain trimers (SCTs), are remarkably stable
at the cell surface compared with native (noncovalently attached) class I
molecules. In this study, we used a structure-based approach to engineer an F
pocket variant SCT of the murine class I molecule Kb that presents
the SIINFEKL epitope of ovalbumin. Mutation of heavy chain residue
Tyr84 (Y84A) in the SCT resulted in enhanced serological and
cytolytic CD8 T cell recognition of the covalently linked peptide due to
better accommodation of the linker extending from the C terminus of the
peptide. These SCTs exhibit significant cell-surface stability, which we
hypothesize is rendered by their ability to continuously and efficiently
rebind the covalently attached peptide. In addition, we demonstrate that SCT
technology can be applied to tetramer construction using recombinant SCTs
expressed in Escherichia coli. SCT-based tetramers could have
applications for the enumeration of T and natural killer cells that recognize
peptide·class I complexes prone to dissociation.
Received for publication, April 9, 2003
, and in revised form, May 5, 2003.
* This work was supported by National Institutes of Health Grants AI19687,
AI42793, and AI27568 (to T. H. H.), Grant T32AI07163 (to L. L.), and Grant
CA86803-04 (to D. H. F.) and by the Burroughs Wellcome Fund (to D. H. F.). The
costs of publication of this article were defrayed in part by the payment of
page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Present address: Surgery Branch, NIH, Bldg. 10, Rm. 2B02, 9000 Rockville
Pike, Bethesda, MD 20892.
||
To whom correspondence should be addressed: Dept. of Genetics, Washington
University School of Medicine, P. O. Box 8232, 660 South Euclid Ave., St.
Louis, MO 63110. Tel.: 314-362-2716; Fax: 314-362-4137; E-mail:
hansen{at}genetics.wustl.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Truscott, X. Wang, L. Lybarger, W. E. Biddison, C. McBerry, J. M. Martinko, J. M. Connolly, G. P. Linette, D. H. Fremont, T. H. Hansen, et al.
Human Major Histocompatibility Complex (MHC) Class I Molecules with Disulfide Traps Secure Disease-related Antigenic Peptides and Exclude Competitor Peptides
J. Biol. Chem.,
March 21, 2008;
283(12):
7480 - 7490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Wilker, J. R. Sedy, V. Grigura, T. L. Murphy, and K. M. Murphy
Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family
Int. Immunol.,
June 1, 2007;
19(6):
763 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Truscott, L. Lybarger, J. M. Martinko, V. E. Mitaksov, D. M. Kranz, J. M. Connolly, D. H. Fremont, and T. H. Hansen
Disulfide Bond Engineering to Trap Peptides in the MHC Class I Binding Groove
J. Immunol.,
May 15, 2007;
178(10):
6280 - 6289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Jones, S. E. Brophy, A. J. Bankovich, L. A. Colf, N. A. Hanick, K. C. Garcia, and D. M. Kranz
Engineering and Characterization of a Stabilized {alpha}1/{alpha}2 Module of the Class I Major Histocompatibility Complex Product Ld
J. Biol. Chem.,
September 1, 2006;
281(35):
25734 - 25744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Margalit, H. M. Sheikhet, Y. Carmi, D. Berko, E. Tzehoval, L. Eisenbach, and G. Gross
Induction of Antitumor Immunity by CTL Epitopes Genetically Linked to Membrane-Anchored {beta}2-Microglobulin
J. Immunol.,
January 1, 2006;
176(1):
217 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Hurchla, J. R. Sedy, M. Gavrielli, C. G. Drake, T. L. Murphy, and K. M. Murphy
B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells
J. Immunol.,
March 15, 2005;
174(6):
3377 - 3385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Berko, Y. Carmi, G. Cafri, S. Ben-Zaken, H. M. Sheikhet, E. Tzehoval, L. Eisenbach, A. Margalit, and G. Gross
Membrane-Anchored {beta}2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules
J. Immunol.,
February 15, 2005;
174(4):
2116 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|